TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	152,054	112,386	240,562	302,627	461,602	496,808
Market Cap Growth	-12.99%	-53.28%	-20.51%	-34.44%	-7.09%	19.98%
Enterprise Value	149,281	130,114	261,518	295,725	419,268	447,505
Last Close Price	5610.00	4315.00	9770.00	12600.00	19300.00	21100.00
PS Ratio	20.73	16.55	49.11	33.19	8127.16	473.63
PB Ratio	2.81	1.79	2.96	4.86	5.11	6.02
P/TBV Ratio	3.71	2.28	3.54	5.10	5.40	6.15
EV/Sales Ratio	20.36	19.16	53.38	32.44	7381.81	426.62
Debt / Equity Ratio	0.68	0.48	0.36	0.37	0.22	0.02
Asset Turnover	0.07	0.06	0.05	0.09	0.00	0.01
Quick Ratio	1.88	1.89	3.19	1.18	9.31	39.00
Current Ratio	2.16	2.15	3.48	1.34	9.38	39.32
Return on Equity (ROE)	-21.68%	-32.75%	-26.54%	-41.16%	-37.32%	-13.85%
Return on Assets (ROA)	-11.04%	-10.30%	-16.12%	-15.05%	-20.22%	-9.30%
Return on Capital (ROIC)	-12.80%	-11.52%	-17.78%	-16.41%	-21.12%	-9.43%
Earnings Yield	-6.90%	-18.37%	-7.45%	-9.86%	-6.85%	-2.44%
FCF Yield	-8.90%	-14.83%	-16.19%	-8.99%	-7.94%	-2.06%
Buyback Yield / Dilution	-11.99%	-5.91%	-1.79%	-0.63%	-1.39%	-17.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.